ChemGenex Pharmaceuticals Limited; ChemGenex to Present Positive Data for Omapro(TM) From Multiple C...
ChemGenex Pharmaceuticals Limited; ChemGenex to Present Positive Data for Omapro(TM) From Multiple Clinical Trials at ASH
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
Omacetaxine is a first-in-class cetaxine with demonstrated clinical activity as a single agent in a range of hematological malignancies. Omacetaxine has a novel mechanism of action, specifically binding to the ribosomal A-site cleft and inhibiting protein translation of short-lived oncoproteins that are upregulated in leukemic cells (particularly C...
Alternative Titles
Full title
ChemGenex Pharmaceuticals Limited; ChemGenex to Present Positive Data for Omapro(TM) From Multiple Clinical Trials at ASH
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_194642453
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_194642453
Other Identifiers
ISSN
1543-6721
E-ISSN
1543-673X
